Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Mandic

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Journal of Cancer Research and Clinical Oncology|June 11, 2014
A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levelsManuel Tonigold, Annette Rossmann, Marie Meinold, et al.
British Journal of Clinical Pharmacology|September 23, 2025
Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centresPernille D Haahr, Anette D Kjeldsen, Annette D Fialla, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Journal of Cancer Research and Clinical Oncology|June 11, 2014
A cisplatin-resistant head and neck cancer cell line with cytoplasmic p53(mut) exhibits ATP-binding cassette transporter upregulation and high glutathione levelsManuel Tonigold, Annette Rossmann, Marie Meinold, et al.
British Journal of Clinical Pharmacology|September 23, 2025
Availability, use, efficacy and safety of bevacizumab in European hereditary haemorrhagic telangiectasia centresPernille D Haahr, Anette D Kjeldsen, Annette D Fialla, et al.
Pageof 7